SCHEMBL27595772

SCHEMBL27595772

O=CC[C@H](c1ccc(F)cc1)c1ccc(C[SH](=O)=O)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.35
HTT P42858 3/20 0.35
CNR2 P34972 2/20 0.35
MITF O75030 1/20 0.35
CNR1 P21554 1/20 0.35
GPR35 Q9HC97 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
XBP1 P17861 1/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP19A1 P11511 2/20 0.33
FFAR1 O14842 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
CACNA2D1 P54289 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27595787 0.87 HTR2A (0.34) LMNACNR2CNR1SLC6A2SLC6A4
SCHEMBL28751429 0.86 CNR2 (0.36) CNR2CYP19A1MEN1KMT2A
SCHEMBL65457 0.84 CACNA2D1 (0.37) LMNAHTTCNR2MITFCNR1
SCHEMBL14198825 0.78 IDO1 (0.46) LMNAKMT2A
SCHEMBL15577528 0.78 HTR2A (0.41) LMNAMAPK1NPSR1ALDH1A1TDP1
SCHEMBL27614458 0.77 LMNA (0.36) LMNAMEN1KMT2ACACNA2D1CACNA1B
SCHEMBL6962007 0.76 SERPINH1 (0.41) LMNAHTTCNR2CNR1MAPK1
SCHEMBL23960436 0.73 CYP19A1 (0.46) CNR2CYP19A1FFAR1CACNA2D1CACNA1B
SCHEMBL2088573 0.69 CYP19A1 (0.40) HTTCYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL3136328 0.69 GABBR2 (0.43) HTTSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1589261-A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) ASTRAZENECA AB (SE) 2005-03-02 CN disclosed